Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of deferasirox versus deferoxamine in transfusional iron overload in beta-thalassaemia
ISRCTN93355192Phase 3Completed
- Sponsor
- Novartis
- Start
- Mar 2003
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, open-label trial in beta thalassemia and transfusional hemosiderosis comparing Deferasirox with Deferoxamine (2 arms). Primary endpoint: Maintenance or reduction of liver iron concentration. Started Mar 2003; status: completed.
02
Drugs
deferasiroxdeferoxamine
03
Conditions
beta thalassemiatransfusional hemosiderosis
Beyond the preview
Go deeper on ISRCTN93355192.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN93355192.